December 12, 2023 /

Community Update with Solid Biosciences on the New INSPIRE DUCHENNE Clinical Study of SGT-003

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Solid Biosciences joined PPMD for a community webinar on December 6, 2023 to provide an overview of INSPIRE DUCHENNE, a first-in-human clinical study evaluating SGT-003, a next-generation microdystrophin gene therapy candidate for the treatment of Duchenne muscular dystrophy. During the webinar, members of Solid’s Clinical and Patient Advocacy teams shared details about SGT-003 and the INSPIRE DUCHENNE study.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo